News
Medpage Today on MSN10h
GLP-1 Leads to Similar Cognitive Outcomes as Other Diabetes Drugs, Trial Data ShowCognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback